13 Stocks Insiders are Buying Now
With the end of 2023 now in sight, many can say with confidence that the much-dreaded recession everyone was talking about will not realize this year.
Sarepta Therapeutics Inc. (SRPT)
Market is closed
News
- First
- << Previous
- 51 - 60
- Next >>
Here’s What Bronte Capital Calls “Sarepta Risk” in the Context of Sarepta Therapeutics (SRPT)
Bronte Capital, an investment management company, released its “Amalthea Fund” third-quarter 2023 investor letter. A copy of the same can be downloaded here.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q3 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Sarepta Therapeutics Third Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.
Analysts on Wall Street Lower Ratings for These 5 Stocks
BofA Securities analyst Arnaud Lehmann recently adjusted the outlook for Ferguson plc (NYSE:FERG) by downgrading the stock from Neutral to Underperform.
5 Best Long-term Stocks To Buy For High Returns
In this piece, we will take a look at the five best long term stocks to buy for high returns.
Hedge Fund and Insider Trading News: George Soros, Ray Dalio, Ken Griffin, Daniel Och, EDL Capital, Rokos Capital Management, Precigen Inc (PGEN), Sigilon Therapeutics, Inc. (SGTX), and More
George Soros has been branded as a bogeyman by the right wing for backing liberal causes around the globe.
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Q2 2023 Earnings Call Transcript
Operator: Good afternoon and welcome to the Sarepta Therapeutics Second Quarter 2023 Earnings Call. At this time, all participants are in listen-only mode.
10 Oversold Biotech Stocks to Buy
In this article, we will take a look at the 10 oversold biotech stocks to buy.
5 Best Economic Recovery Stocks to Buy
In this piece, we will take a look at the five best economic recovery stocks to buy.
- First
- << Previous
- 51 - 60
- Next >>
Billionaire Hedge Funds
